APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Buprenorphine Transdermal Patches

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Buprenorphine Transdermal Patches Industry Growth and Trends Forecast to 2032

Report ID 173973220120 December 202571 pages

Choose your research edition.

Industry ResearchBuprenorphine Transdermal Patches Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Buprenorphine Transdermal Patches Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Buprenorphine Transdermal Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buprenorphine Transdermal Patches Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Buprenorphine Transdermal Patches Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Buprenorphine Transdermal Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buprenorphine Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buprenorphine Transdermal Patches include Luye Pharma, PurduePharma and Grunenthal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Buprenorphine Transdermal Patches market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Buprenorphine Transdermal Patches market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Buprenorphine Transdermal Patches market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Buprenorphine Transdermal Patches.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Buprenorphine Transdermal Patches market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Buprenorphine Transdermal Patches Market by Company

Luye Pharma

PurduePharma

Grunenthal

Buprenorphine Transdermal Patches Segment by Type

10mcg/h

15 mcg/h

20 mcg/h

5mcg/h

7.5mcg/h

Buprenorphine Transdermal Patches Segment by Application

Relieve Cancer Pain

Other

Buprenorphine Transdermal Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Transdermal Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Transdermal Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Transdermal Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Buprenorphine Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mcg/h Table 2. Major Company of 15 mcg/h Table 3. Major Company of 20 mcg/h Table 4. Major Company of 5mcg/h Table 5. Major Company of 7.5mcg/h Table 6. Global Buprenorphine Transdermal Patches Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 8. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Type (2021-2026) Table 9. Global Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 10. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Type (2021-2026) Table 11. Global Buprenorphine Transdermal Patches Price by Type (2021-2026) & (US$/unit) Table 12. Global Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 13. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Type (2027-2032) Table 14. Global Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (US$ Million) Table 15. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Type (2027-2032) Table 16. Global Buprenorphine Transdermal Patches Price by Type (2027-2032) & (US$/unit) Table 17. North America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 18. North America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 20. Europe Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 24. Latin America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 27. Buprenorphine Transdermal Patches Industry Trends Table 28. Buprenorphine Transdermal Patches Industry Drivers Table 29. Buprenorphine Transdermal Patches Industry Opportunities and Challenges Table 30. Buprenorphine Transdermal Patches Industry Restraints Table 31. Global Buprenorphine Transdermal Patches Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Buprenorphine Transdermal Patches Revenue Market Share by Company (2021-2026) Table 33. Global Buprenorphine Transdermal Patches Sales by Company (2021-2026) & (k units) Table 34. Global Buprenorphine Transdermal Patches Sales Share by Company (2021-2026) Table 35. Global Buprenorphine Transdermal Patches Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Buprenorphine Transdermal Patches Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Buprenorphine Transdermal Patches Major Company Production Sites and Headquarters Table 38. Global Buprenorphine Transdermal Patches Company, Product Type & Application Table 39. Global Buprenorphine Transdermal Patches Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Buprenorphine Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Buprenorphine Transdermal Patches Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (k units) Table 44. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Region (2021-2026) Table 45. Global Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (US$ Million) Table 46. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Region (2021-2026) Table 47. Global Buprenorphine Transdermal Patches Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Buprenorphine Transdermal Patches Sales by Region (2027-2032) & (k units) Table 49. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Region (2027-2032) Table 50. Global Buprenorphine Transdermal Patches Sales by Region (2027-2032) & (US$ Million) Table 51. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Region (2027-2032) Table 52. Global Buprenorphine Transdermal Patches Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Buprenorphine Transdermal Patches Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 55. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Application (2021-2026) Table 56. Global Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 57. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Application (2021-2026) Table 58. Global Buprenorphine Transdermal Patches Price by Application (2021-2026) & (US$/unit) Table 59. Global Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 60. Global Buprenorphine Transdermal Patches Sales Market Share in Volume by Application (2027-2032) Table 61. Global Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (US$ Million) Table 62. Global Buprenorphine Transdermal Patches Sales Market Share in Value by Application (2027-2032) Table 63. Global Buprenorphine Transdermal Patches Price by Application (2027-2032) & (US$/unit) Table 64. North America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 65. North America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 67. Europe Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 71. Latin America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 74. Luye Pharma Company Information Table 75. Luye Pharma Business Overview Table 76. Luye Pharma Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Luye Pharma Buprenorphine Transdermal Patches Product Portfolio Table 78. Luye Pharma Recent Development Table 79. PurduePharma Company Information Table 80. PurduePharma Business Overview Table 81. PurduePharma Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. PurduePharma Buprenorphine Transdermal Patches Product Portfolio Table 83. PurduePharma Recent Development Table 84. Grunenthal Company Information Table 85. Grunenthal Business Overview Table 86. Grunenthal Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Grunenthal Buprenorphine Transdermal Patches Product Portfolio Table 88. Grunenthal Recent Development Table 89. North America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 90. North America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 91. North America Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2026) Table 92. North America Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 93. North America Buprenorphine Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 94. North America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 95. North America Buprenorphine Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 96. North America Buprenorphine Transdermal Patches Market Share by Country (2021-2026) Table 97. North America Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 98. North America Buprenorphine Transdermal Patches Market Share Forecast by Country (2027-2032) Table 99. Europe Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 100. Europe Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 101. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2026) Table 102. Europe Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 103. Europe Buprenorphine Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 104. Europe Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. Europe Buprenorphine Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 106. Europe Buprenorphine Transdermal Patches Market Share by Country (2021-2026) Table 107. Europe Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. Europe Buprenorphine Transdermal Patches Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 111. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2026) Table 112. Asia-Pacific Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 113. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Buprenorphine Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 116. Asia-Pacific Buprenorphine Transdermal Patches Market Share by Country (2021-2026) Table 117. Asia-Pacific Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Asia-Pacific Buprenorphine Transdermal Patches Market Share Forecast by Country (2027-2032) Table 119. Latin America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Latin America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 121. Latin America Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2026) Table 122. Latin America Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 123. Latin America Buprenorphine Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 124. Latin America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Latin America Buprenorphine Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 126. Latin America Buprenorphine Transdermal Patches Market Share by Country (2021-2026) Table 127. Latin America Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Latin America Buprenorphine Transdermal Patches Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 131. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2021-2026) Table 132. Middle East and Africa Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 133. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Buprenorphine Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Buprenorphine Transdermal Patches Market Share by Country (2021-2026) Table 137. Middle East and Africa Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Middle East and Africa Buprenorphine Transdermal Patches Market Share Forecast by Country (2027-2032) Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Buprenorphine Transdermal Patches Distributors List Table 142. Buprenorphine Transdermal Patches Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Buprenorphine Transdermal Patches Image Figure 2. Global Buprenorphine Transdermal Patches Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buprenorphine Transdermal Patches Market Size (2021-2032) & (US$ Million) Figure 4. Global Buprenorphine Transdermal Patches Sales (2021-2032) & (k units) Figure 5. 10mcg/h Image Figure 6. Global 10mcg/h Sales YoY Growth (2021-2032) & (k units) Figure 7. 15 mcg/h Image Figure 8. Global 15 mcg/h Sales YoY Growth (2021-2032) & (k units) Figure 9. 20 mcg/h Image Figure 10. Global 20 mcg/h Sales YoY Growth (2021-2032) & (k units) Figure 11. 5mcg/h Image Figure 12. Global 5mcg/h Sales YoY Growth (2021-2032) & (k units) Figure 13. 7.5mcg/h Image Figure 14. Global 7.5mcg/h Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Buprenorphine Transdermal Patches Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Buprenorphine Transdermal Patches Market Share by Type 2025 VS 2032 Figure 17. North America Buprenorphine Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 18. North America Buprenorphine Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 19. Europe Buprenorphine Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 20. Europe Buprenorphine Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 23. Latin America Buprenorphine Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Buprenorphine Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Buprenorphine Transdermal Patches Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Relieve Cancer Pain Image Figure 30. Global Relieve Cancer Pain Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Buprenorphine Transdermal Patches Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Buprenorphine Transdermal Patches Market Share by Application 2025 VS 2032 Figure 35. North America Buprenorphine Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 36. North America Buprenorphine Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 37. Europe Buprenorphine Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 38. Europe Buprenorphine Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 41. Latin America Buprenorphine Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Buprenorphine Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 45. North America Buprenorphine Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Buprenorphine Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Buprenorphine Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Buprenorphine Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Buprenorphine Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Buprenorphine Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Buprenorphine Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Buprenorphine Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Buprenorphine Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Buprenorphine Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Buprenorphine Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Buprenorphine Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Buprenorphine Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Buprenorphine Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Buprenorphine Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Buprenorphine Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Buprenorphine Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Buprenorphine Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Buprenorphine Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Buprenorphine Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Buprenorphine Transdermal Patches Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Buprenorphine Transdermal Patches Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mcg/h
  • 15 mcg/h
  • 20 mcg/h
  • 5mcg/h
  • 7.5mcg/h
Applications
  • Relieve Cancer Pain
  • Other
Companies covered
  • Luye Pharma
  • PurduePharma
  • Grunenthal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buprenorphine Transdermal Patches Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Buprenorphine Transdermal Patches Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Buprenorphine Transdermal Patches Market by Type
  6. 1.3.1 10mcg/h
  7. 1.3.2 15 mcg/h
  8. 1.3.3 20 mcg/h
  9. 1.3.4 5mcg/h
  10. 1.3.5 7.5mcg/h
  11. 1.4 Global Buprenorphine Transdermal Patches Market Size by Type
  12. 1.4.1 Global Buprenorphine Transdermal Patches Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Buprenorphine Transdermal Patches Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Buprenorphine Transdermal Patches Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Buprenorphine Transdermal Patches Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Buprenorphine Transdermal Patches Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Buprenorphine Transdermal Patches Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Buprenorphine Transdermal Patches Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Buprenorphine Transdermal Patches Industry Trends
  2. 2.2 Buprenorphine Transdermal Patches Industry Drivers
  3. 2.3 Buprenorphine Transdermal Patches Industry Opportunities and Challenges
  4. 2.4 Buprenorphine Transdermal Patches Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Buprenorphine Transdermal Patches Revenue (2021-2026)
  2. 3.2 Global Top Players by Buprenorphine Transdermal Patches Sales (2021-2026)
  3. 3.3 Global Top Players by Buprenorphine Transdermal Patches Price (2021-2026)
  4. 3.4 Global Buprenorphine Transdermal Patches Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buprenorphine Transdermal Patches Major Company Production Sites & Headquarters
  6. 3.6 Global Buprenorphine Transdermal Patches Company, Product Type & Application
  7. 3.7 Global Buprenorphine Transdermal Patches Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buprenorphine Transdermal Patches Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buprenorphine Transdermal Patches Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buprenorphine Transdermal Patches Tier 1, Tier 2, and Tier 3
4 Buprenorphine Transdermal Patches Regional Status and Outlook
  1. 4.1 Global Buprenorphine Transdermal Patches Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Buprenorphine Transdermal Patches Historic Market Size by Region
  3. 4.2.1 Global Buprenorphine Transdermal Patches Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Buprenorphine Transdermal Patches Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Buprenorphine Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Region
  7. 4.3.1 Global Buprenorphine Transdermal Patches Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Buprenorphine Transdermal Patches Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Buprenorphine Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Buprenorphine Transdermal Patches by Application
  1. 5.1 Buprenorphine Transdermal Patches Market by Application
  2. 5.1.1 Relieve Cancer Pain
  3. 5.1.2 Other
  4. 5.2 Global Buprenorphine Transdermal Patches Market Size by Application
  5. 5.2.1 Global Buprenorphine Transdermal Patches Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Buprenorphine Transdermal Patches Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Buprenorphine Transdermal Patches Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Buprenorphine Transdermal Patches Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Buprenorphine Transdermal Patches Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Buprenorphine Transdermal Patches Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Buprenorphine Transdermal Patches Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Buprenorphine Transdermal Patches Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Luye Pharma
  2. 6.1.1 Luye Pharma Company Information
  3. 6.1.2 Luye Pharma Business Overview
  4. 6.1.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Luye Pharma Buprenorphine Transdermal Patches Product Portfolio
  6. 6.1.5 Luye Pharma Recent Developments
  7. 6.2 PurduePharma
  8. 6.2.1 PurduePharma Company Information
  9. 6.2.2 PurduePharma Business Overview
  10. 6.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 PurduePharma Buprenorphine Transdermal Patches Product Portfolio
  12. 6.2.5 PurduePharma Recent Developments
  13. 6.3 Grunenthal
  14. 6.3.1 Grunenthal Company Information
  15. 6.3.2 Grunenthal Business Overview
  16. 6.3.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grunenthal Buprenorphine Transdermal Patches Product Portfolio
  18. 6.3.5 Grunenthal Recent Developments
7 North America by Country
  1. 7.1 North America Buprenorphine Transdermal Patches Sales by Country
  2. 7.1.1 North America Buprenorphine Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Buprenorphine Transdermal Patches Sales by Country (2021-2026)
  4. 7.1.3 North America Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 7.2 North America Buprenorphine Transdermal Patches Market Size by Country
  6. 7.2.1 North America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Buprenorphine Transdermal Patches Market Size by Country (2021-2026)
  8. 7.2.3 North America Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Buprenorphine Transdermal Patches Sales by Country
  2. 8.1.1 Europe Buprenorphine Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Buprenorphine Transdermal Patches Sales by Country (2021-2026)
  4. 8.1.3 Europe Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Buprenorphine Transdermal Patches Market Size by Country
  6. 8.2.1 Europe Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Buprenorphine Transdermal Patches Market Size by Country (2021-2026)
  8. 8.2.3 Europe Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Buprenorphine Transdermal Patches Sales by Country
  2. 9.1.1 Asia-Pacific Buprenorphine Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Buprenorphine Transdermal Patches Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Buprenorphine Transdermal Patches Market Size by Country
  6. 9.2.1 Asia-Pacific Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Buprenorphine Transdermal Patches Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Buprenorphine Transdermal Patches Sales by Country
  2. 10.1.1 South America Buprenorphine Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Buprenorphine Transdermal Patches Sales by Country (2021-2026)
  4. 10.1.3 South America Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 10.2 South America Buprenorphine Transdermal Patches Market Size by Country
  6. 10.2.1 South America Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Buprenorphine Transdermal Patches Market Size by Country (2021-2026)
  8. 10.2.3 South America Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Buprenorphine Transdermal Patches Sales by Country
  2. 11.1.1 Middle East and Africa Buprenorphine Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Buprenorphine Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Buprenorphine Transdermal Patches Market Size by Country
  6. 11.2.1 Middle East and Africa Buprenorphine Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Buprenorphine Transdermal Patches Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Buprenorphine Transdermal Patches Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Buprenorphine Transdermal Patches Value Chain Analysis
  2. 12.1.1 Buprenorphine Transdermal Patches Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Buprenorphine Transdermal Patches Production Mode & Process
  7. 12.2 Buprenorphine Transdermal Patches Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Buprenorphine Transdermal Patches Distributors
  10. 12.2.3 Buprenorphine Transdermal Patches Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst